Structure via PubChem · Public domain (PubChem)
leniolisib
Sign in to saveAlso known as CDZ173
Leniolisib (INN), sold under the brand name Joenja, is a medication used for the treatment of activated phosphoinositide 3-kinase delta syndrome (APDS). It is a kinase inhibitor that is taken by mouth.
Chemical data
- Formula
- C21H25F3N6O2
- Molecular weight
- 450.5 g/mol
- IUPAC name
- 1-[(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)-3-pyridinyl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]propan-1-one
- SMILES
- CCC(=O)N1CC[C@@H](C1)NC2=NC=NC3=C2CN(CC3)C4=CC(=C(N=C4)OC)C(F)(F)F
- InChIKey
- MWKYMZXCGYXLPL-ZDUSSCGKSA-N
- XLogP
- 2.5
- Polar surface area
- 83.5 Ų
- H-bond donors
- 1
- H-bond acceptors
- 10
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- First approval
- 2023
- Admin. routes
- oral
- Indications
- neoplasm
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 450.199
Show 5 more facts
- canonical SMILES
- CCC(=O)N1CCC(C1)NC2=NC=NC3=C2CN(CC3)C4=CN=C(C(=C4)C(F)(F)F)OC
- chemical formula
- C₂₁H₂₅F₃N₆O₂
- isomeric SMILES
- CCC(=O)N1CC[C@@H](C1)NC2=NC=NC3=C2CN(CC3)C4=CN=C(C(=C4)C(F)(F)F)OC
- World Health Organisation international non-proprietary name
- leniolisib
- Commons category
- Leniolisib
Sources (2)
via Wikidata · CC0
~3 min read
Encyclopedic overview
6 sectionsContents
- Medical uses
- Mechanism of action
- Adverse effects
- History
- References
- External links
Leniolisib (INN), sold under the brand name Joenja, is a medication used for the treatment of activated phosphoinositide 3-kinase delta syndrome (APDS). It is a kinase inhibitor that is taken by mouth.
The most common side effects include headache, sinusitis, and atopic dermatitis.
Excerpted from Wikipedia’s “leniolisib” article, available under the CC BY-SA 4.0 licence.